Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · IEX Real-Time Price · USD
1.970
-0.190 (-8.80%)
At close: Apr 24, 2024, 4:00 PM
2.060
+0.090 (4.57%)
After-hours: Apr 24, 2024, 7:13 PM EDT

Eledon Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Net Income
-40.33-87.97-34.51-22.81-16.01-14.07-13.12-5.66-45.09-23.3
Upgrade
Depreciation & Amortization
0.370.370.20.180.180.010.020.040.110.02
Upgrade
Share-Based Compensation
6.558.157.93.171.311.540.580.172.92.11
Upgrade
Other Operating Activities
-6.1251.02-2.514.250.660.62-2.430.530.840.05
Upgrade
Operating Cash Flow
-39.53-28.42-28.91-15.21-13.86-11.89-14.94-4.92-41.24-21.12
Upgrade
Capital Expenditures
0000000.010-0.57-0.03
Upgrade
Acquisitions
00011.040023.25000
Upgrade
Change in Investments
-45.290000000-39.880
Upgrade
Other Investing Activities
---------0.07-0.15
Upgrade
Investing Cash Flow
-45.290011.040023.260-40.51-0.18
Upgrade
Share Issuance / Repurchase
33.020-0.4514.369.687.567.8700.4694.64
Upgrade
Debt Issued / Paid
00000002.9300
Upgrade
Other Financing Activities
---95.23----0.050.16
Upgrade
Financing Cash Flow
33.020-0.45109.589.687.567.872.930.5194.8
Upgrade
Net Cash Flow
-51.8-28.42-29.36105.4-4.18-4.3316.19-1.99-81.2373.5
Upgrade
Free Cash Flow
-39.53-28.42-28.91-15.21-13.86-11.89-14.93-4.92-41.8-21.15
Upgrade
Free Cash Flow Per Share
-1.61-1.99-1.95-10.48-21.14-23.77-57.46-231.47-301.18-529.53
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).